(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.28%) $78.33
(0.28%) $2.15
(0.50%) $2 320.20
(1.73%) $27.15
(-0.41%) $961.30
(0.01%) $0.929
(-0.02%) $10.87
(-0.02%) $0.797
(0.00%) $91.45
2 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings...
Stats | |
---|---|
Today's Volume | 66 583.00 |
Average Volume | 97 831.00 |
Market Cap | 17.33M |
Next earnings date | ( $-0.280 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.00900 (0.87%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-19 | Nantahala Capital Management, Llc | Buy | 324 675 | 2024 Pre-Funded Warrants |
2024-03-15 | Nantahala Capital Management, Llc | Buy | 755 000 | Common Stock |
2024-03-15 | Nantahala Capital Management, Llc | Sell | 755 000 | Put Option (obligation to buy) |
2024-03-12 | Angotti Vincent J. | Buy | 8 000 | Common Stock |
2024-03-11 | Angotti Vincent J. | Buy | 1 000 | Common Stock |
INSIDER POWER |
---|
41.09 |
Last 32 transactions |
Buy: 12 440 706 | Sell: 5 181 856 |
Volume Correlation
Talphera, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Talphera, Inc. Correlation - Currency/Commodity
Talphera, Inc. Financials
Annual | 2023 |
Revenue: | $651 000 |
Gross Profit: | $340 000 (52.23 %) |
EPS: | $-1.290 |
FY | 2023 |
Revenue: | $651 000 |
Gross Profit: | $340 000 (52.23 %) |
EPS: | $-1.290 |
Financial Reports:
No articles found.
Talphera, Inc.
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. Talphera, Inc. was incorporated in 2005 and is headquartered in San Mateo, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators